Atlas Trials

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Clinical trial NCT01021956 · TERMINATED

Trial details

NCT number
NCT01021956
Sponsor
Steba Biotech S.A.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Macular DegenerationChoroidal Neovascularization
Start date
2010-06-01
Primary completion
2012-05-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.